HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arjan A van de Loosdrecht Selected Research

Sudan Black B

3/2013A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arjan A van de Loosdrecht Research Topics

Disease

31Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 08/2004
24Neoplasms (Cancer)
05/2024 - 11/2004
21Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2023 - 04/2009
21Leukemia
11/2023 - 03/2004
7Residual Neoplasm
12/2014 - 03/2006
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2017 - 01/2014
3Blister (Bulla)
11/2015 - 01/2014
3Lymphoma (Lymphomas)
08/2010 - 03/2004
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2008 - 11/2004
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2024 - 04/2013
2Anemia
08/2023 - 10/2021
2Infections
08/2022 - 10/2021
2Hematologic Neoplasms (Hematological Malignancy)
10/2021 - 08/2020
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021 - 06/2014
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2023
1Hemochromatosis (Bronze Diabetes)
08/2023
1Iron Overload
08/2023
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2023
1Neutropenia
08/2022
1Blood Platelet Disorders (Thrombocytopathy)
10/2021
1Hemostatic Disorders
10/2021
1Refractory Anemia with Excess of Blasts (RAEM)
01/2019
1Chromosome Aberrations (Chromosome Abnormalities)
01/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
11/2016
1Cytopenia
02/2016
1B-Cell Leukemia (Leukemia, B Cell)
07/2014
1Systemic Scleroderma (Systemic Sclerosis)
06/2014
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2013
1Hemorrhage
11/2011
1Acute Promyelocytic Leukemia
11/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2011
1Thrombocytosis (Thrombocythemia)
07/2010
1Refractory Anemia
07/2010

Drug/Important Bio-Agent (IBA)

17AntigensIBA
01/2023 - 08/2004
9VaccinesIBA
11/2023 - 01/2006
8Peptides (Polypeptides)IBA
11/2015 - 01/2010
6invariant chain (Ii-Key)IBA
12/2014 - 03/2010
5Azacitidine (5 Azacytidine)FDA Link
01/2019 - 12/2011
4Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2010
4Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2008
3Interleukin-4 (Interleukin 4)IBA
11/2015 - 01/2003
3Histocompatibility Antigens Class IIIBA
04/2011 - 03/2010
2Clofarabine (Clolar)FDA Link
05/2024 - 03/2017
2Ferritins (Ferritin)IBA
08/2023 - 09/2012
2RNA Splicing FactorsIBA
01/2021 - 01/2020
2CytokinesIBA
04/2014 - 01/2003
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2014 - 01/2003
2Lenalidomide (CC 5013)FDA Link
04/2013 - 07/2010
2Imatinib Mesylate (Gleevec)FDA Link
04/2011 - 07/2006
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2011 - 04/2009
2HLA-DR Antigens (HLA-DR)IBA
04/2011 - 03/2010
2Monoclonal AntibodiesIBA
08/2010 - 01/2006
1HepcidinsIBA
08/2023
1GlycoconjugatesIBA
01/2023
1Anti-Infective Agents (Microbicides)IBA
08/2022
1luspaterceptIBA
01/2021
1ThrombomodulinIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2019
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
01/2019
1Transcription Factor 4IBA
01/2019
1LigandsIBA
01/2019
1Polysaccharides (Glycans)IBA
01/2019
1Mannose (D-Mannose)IBA
01/2019
1Transferrin (beta 2 Transferrin)IBA
01/2018
1IronIBA
01/2018
1Growth Differentiation Factor 15IBA
01/2018
1Transferrin Receptors (Transferrin Receptor)IBA
01/2018
1Cytarabine (Cytosar-U)FDA LinkGeneric
03/2017
1Amsacrine (AMSA)IBA
03/2017
1DiamondIBA
11/2016
1PlasticsIBA
02/2016
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
07/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014
1EpitopesIBA
04/2014
1MicroRNAs (MicroRNA)IBA
04/2013
1Sudan Black BIBA
03/2013
1Peroxidase (Myeloperoxidase)IBA
03/2013
1Bevacizumab (Avastin)FDA Link
12/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2011
1nilotinibFDA Link
04/2011
1Tyrosine Kinase InhibitorsIBA
04/2011
1Histocompatibility Antigens Class IIBA
04/2011
1Dasatinib (BMS 354825)FDA Link
04/2011
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2010

Therapy/Procedure

15Immunotherapy
05/2024 - 03/2004
12Therapeutics
10/2021 - 03/2004
7Surgical Instruments (Clip)
06/2014 - 08/2004
6Drug Therapy (Chemotherapy)
01/2019 - 11/2004
4Hematopoietic Stem Cell Transplantation
10/2021 - 06/2014
3Stem Cell Transplantation
11/2023 - 12/2009
2Investigational Therapies (Experimental Therapy)
01/2011 - 01/2010
1Hemodilution
01/2024
1Induction Chemotherapy
01/2024
1Chelation Therapy (Therapy, Chelation)
08/2023
1Erythrocyte Transfusion
01/2018
1Transplantation
01/2017
1Homologous Transplantation
01/2016
1Aftercare (After-Treatment)
06/2014